SEFAM is a French company specialized in the design, manufature and distribution of diagnostic and therapy equipment for sleep-disordered breathing.
The company SEFAM (Société d’Etude et de Fabrication d’Appareillage Médical i.e the company for the Study and Manufacture of Medical Equipment in English) was founded by Pierrick Haan in 1982. SEFAM entered the respiratory market for sleep disorders in 1985 with the development of the first continuous positive airway pressure (CPAP) device in Europe for the treatment of the Obstructive Sleep Apnea Syndrome (OSA). At that time, the University Hospital of Nancy excelled in the field of respiratory medicine under the supervision of Professor Paul Sadoul, department head and professor of pulmonology, director of INSERM unit 14 (respiratory pathophysiology) and founding president of ANTADIR. It is within the INSERM unit 14 the first prototype of CPAP was manufactured, named the SEFAM.
Between 1983 and 1994, SEFAM developed, manufactured and marketed innovative solutions for screening, diagnosis, treatment and monitoring of the respiratory sleep disorders and respiratory failure:
Different models of CPAP, Auto-CPAP and Bi-Levels (MiniP+, Rem+, Rem+ Control, Rem+ range, Ventil+).
Equipment for the diagnosis of respiratory sleep disorders (RESPISOMNOGRAPHE, Mini SOMNO).
Home ventilators and oxygen concentrators.
In 1994 SEFAM was sold to Puritan Bennett, itself acquired by Nellcor in 1995, absorbed by Mallinckrodt in 1997, and then by Tyco in 2000. Tyco’s medical division was spun off in 2007 and became COVIDIEN. During all these changes, the Nancy site continued the development and manufacture of equipment for the diagnosis and treatment of respiratory sleep disorders (HypnoPTT, GoodKnight 418 range, GoodKnight 420 range, Sandman range).
In 2010, the SEFAM brand is reactivated
In 2011, the relaunch of the 100% French brand is celebrated by the placing on the market of a new range of devices treating respiratory sleep disorders: DreamStar range.